BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients.
BACKGROUND:The BRAF V600E and telomerase reverse transcriptase (TERT) promoter mutations have been reported in papillary thyroid carcinoma (PTC). The aim of this retrospective cross-sectional study was to add further information regarding the prevalence of the BRAF V600E and TERT promoter mutations...
Main Authors: | Jian Sun, Jing Zhang, Junliang Lu, Jie Gao, Xinyu Ren, Lianghong Teng, Huanli Duan, Yansong Lin, Xiaoyi Li, Bo Zhang, Zhiyong Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4827831?pdf=render |
Similar Items
-
BRAF and TERT mutations in papillary thyroid cancer patients of Latino ancestry
by: Ana P Estrada-Flórez, et al.
Published: (2019-09-01) -
Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China
by: Meiling Huang, et al.
Published: (2019-07-01) -
Association between BRAF V600E Mutation and Ultrasound Features in Papillary Thyroid Carcinoma Patients with and without Hashimoto’s Thyroiditis
by: Qin Zhang, et al.
Published: (2017-07-01) -
Clinical significance of BRAF V600E mutation in low risk papillary thyroid carcinoma
by: He-Jiun Jiang, et al.
Published: (2018) -
Rare cell detection of BRAF-V600E mutation in the patients with papillary thyroid carcinoma
by: Kong Kit Leong, et al.
Published: (2016)